Position in DXCM
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,095,420
+$454,419 QoQ
Shares Held
17,443
+80.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026FOX RUN MANAGEMENT, L.L.C. holds $13,348,647 across 17 Medical Devices names. DXCM ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
8,309 | $1,743,560 | |
| 2 | ABT |
Abbott Laboratories
|
16,852 | $1,730,194 | |
| 3 | EW |
Edwards Lifesciences Corp
|
16,166 | $1,294,573 | |
| 4 | DXCM |
Dexcom Inc
This page
|
17,443 | $1,095,420 | |
| 5 | BSX |
Boston Scientific Corp
|
16,055 | $1,007,451 | |
| 6 | SYK |
Stryker Corp
|
2,888 | $948,967 | |
| 7 | ITGR |
Integer Holdings Corp
|
9,620 | $846,560 | |
| 8 | CNMD |
CONMED Corp
|
19,776 | $699,279 |
All Filings in DXCM
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,095,420 | 17,443 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $641,001 | 9,658 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,235,982 | 18,368 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $582,718 | 8,533 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $240,853 | 3,097 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,045,622 | 15,597 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $801,369 | 7,068 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $297,629 | 2,316 | Shares | Sole | 2023-08-11 | |
| 2021-12-31 | $235,184 | 438 | Shares | Sole | 2022-02-09 | |
| 2020-06-30 | $327,968 | 809 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||